The Food and Drug Administration (FDA) has approved Rybrevant Faspro™, a subcutaneous (SC) formulation of amivantamab for all indications approved for the ...

TRITON3 trial data support FDA traditional approval of rucaparib for treating adults with BRCA-mutated metastatic castration-resistant prostate cancer.

HealthDay News — Flu season is getting an early start in New York City, with doctors reporting a sharp jump in cases weeks sooner than normal.

No reduction seen in in-hospital death by day 28 with use of ketamine rather than etomidate to induce anesthesia in critically ill adults undergoing tracheal intubation ...

The FDA said retailers were first notified of the recall November 8, after health officials determined the formula was the likely source of the outbreak. The company expanded the recall to all ByHeart ...

Odds of vertebral compression fractures or surgical intervention were significantly lower among GLP-1 RA users ...

Fasedienol is a first-in-class pherine nasal spray that is designed to modulate the olfactory-limbic amygdala fear and anxiety neurocircuits.

Since 1991, the CDC had recommended that all newborns receive a hepatitis B shot within 24 hours of birth to prevent early infections. The change follows a vote earlier this month by the CDC’s vaccine ...

The Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa), an interleukin-5 antagonist, for add-on maintenance treatment of severe asthma characterized by an eosinophilic ...

The Viaskin Peanut patch showed clinically meaningful desensitization and a favorable safety profile in young children with peanut allergy.

The approval was based on a randomized, double-blind, placebo-controlled phase 3 trial, which included 447 postmenopausal women with acquired, generalized HSDD.